journal article·2022-06

Rational design of ibuprofen-based redox-responsive anti-cancer polymeric drug delivery systems

Dule Hao, Zheng Zhang, Yu Cheng, Long Cheng, Yuanhui Ji

Journal of Materials Science· Volume 57· Issue 24
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Inflammatory mediators and NSAID effects · Nanoplatforms for cancer theranostics · Estrogen and related hormone effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Feng RM, Zong YN, Cao SM et al (2019) Current cancer situation in China: Good or bad news from the 2018 Global Cancer Statistics? Cancer Commun 39:22–3410.1186/s40880-019-0368-6 ↗
2. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. Ca-Cancer J Clin 70:7–3010.3322/caac.21590 ↗
3. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–86710.1038/nature01322 ↗
4. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–44410.1038/nature07205 ↗
5. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–89910.1016/j.cell.2010.01.025 ↗
6. Crusz SM, Balkwill FR (2015) Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12:584–59610.1038/nrclinonc.2015.105 ↗
7. Li Z, Sun J, Huang Y et al (2018) A nanomicellar prodrug carrier based on ibuprofen-conjugated polymer for co-delivery of doxorubicin. Front Pharmacol 9:78110.3389/fphar.2018.00781 ↗
8. Piazza GA, Keeton AB, Tinsley HN et al (2010) NSAIDs: old drugs reveal new anticancer targets. Pharmaceuticals 3:1652–166710.3390/ph3051652 ↗
9. Gouda AM, Beshr EA, Almalki FA et al (2019) Arylpropionic acid-derived NSAIDs: new insights on derivatization, anticancer activity and potential mechanism of action. Bioorg Chem 92:10322410.1016/j.bioorg.2019.103224 ↗
10. Yurtdas-Kirimlioglu G, Gorgulu S, Berkman MS (2020) Novel approaches to cancer therapy with ibuprofen-loadedEudragit(R)RS 100and/or octadecylamine-modified PLGA nanoparticles by assessment of their effects on apoptosis. Drug Dev Ind Pharm 46:1133–114910.1080/03639045.2020.1776319 ↗
11. Zhang L, Li G, Gao M et al (2016) RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin. Colloids and Surfaces B-Biointerfaces 144:81–8910.1016/j.colsurfb.2016.03.077 ↗
12. Andrews J, Djakiew D, Krygier S et al (2002) Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemother Pharmacol 50:277–28410.1007/s00280-002-0485-8 ↗
13. Friis S, Riis AH, Erichsen R et al (2015) Sorensen, Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk a population-based, case-control study. Ann Intern Med 163:347–37010.7326/M15-0039 ↗
14. Cao PX, Bae Y (2012) Polymer nanoparticulate drug delivery and combination cancer therapy. Future Oncol 8:1471–148010.2217/fon.12.139 ↗
15. Paris JL, Cabanas MV, Manzano M et al (2015) Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers. ACS Nano 9:11023–1103310.1021/acsnano.5b04378 ↗
16. Yahia-Ammar A, Sierra D, Merola F et al (2016) Self-assembled gold nanoclusters for bright fluorescence imaging and enhanced drug delivery. ACS Nano 10:2591–259910.1021/acsnano.5b07596 ↗
17. Kumar S, Rani R, Dilbaghi N et al (2017) Carbon nanotubes: a novel material for multifaceted applications in human healthcare. Chem Soc Rev 46:158–19610.1039/C6CS00517A ↗
18. Yang K, Feng L, Liu Z (2016) Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Adv Drug Del Rev 105:228–24110.1016/j.addr.2016.05.015 ↗
19. Xue B, Kozlovskaya V, Kharlampieva E (2017) Shaped stimuli-responsive hydrogel particles: syntheses, properties and biological responses. J Mater Chem B 5:9–3510.1039/C6TB02746F ↗
20. Zhang FD, Liu Y, Xu JC et al (2015) Binding and conformation of dendrimer-based drug delivery systems: a molecular dynamics study. Adv Manuf 3:221–23110.1007/s40436-015-0120-7 ↗
21. Kohori F, Yokoyama M, Sakai K et al (2002) Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. J Control Release 78:155–16310.1016/S0168-3659(01)00492-8 ↗
22. Lee KS, Chung HC, Im SA et al (2008) Multicenter phase II trial of genexol-PM, a cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat 108:241–25010.1007/s10549-007-9591-y ↗
23. Yang JY, Kopecek J (2014) Macromolecular therapeutics. J Control Release 190:288–30310.1016/j.jconrel.2014.04.013 ↗
24. Koziolová E, Venclíková K, Etrych T (2018) Polymer-drug conjugates in inflammation treatment. Physiol Res 67:S281–S29210.33549/physiolres.933977 ↗
25. Zeng Z, Wei ZL, Ma LM et al (2017) pH-Responsive nanoparticles based on ibuprofen prodrug as drug carriers for inhibition of primary tumor growth and metastasis. J Mater Chem B 5:6860–686810.1039/C7TB01288H ↗
26. Gao S, Tang G, Hua D et al (2019) Stimuli-responsive bio-based polymeric systems and their applications. J Mater Chem B 7:709–72910.1039/C8TB02491J ↗
27. Lv SX, Tang ZH, Zhang DW et al (2014) Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel. J Control Release 194:220–22710.1016/j.jconrel.2014.09.009 ↗
28. Tan JJ, Deng ZY, Liu GH et al (2018) Anti-inflammatory polymersomes of redox-responsive polyprodrug amphiphiles with inflammation-triggered indomethacin release characteristics. Biomaterials 178:608–61910.1016/j.biomaterials.2018.03.035 ↗
29. Huynh L, Neale C, Pomes R et al (2012) Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery. Nanomed-Nanotechnol 8:20–3610.1016/j.nano.2011.05.006 ↗
30. Ji YH, Lesniak AK, Prudic A et al (2016) Drug release kinetics and mechanism from PLGA formulations. AlChE J 62:4055–406510.1002/aic.15282 ↗
31. Liu G, Sun H, Liu GK et al (2018) A molecular dynamics study of cellulose inclusion complexes in NaOH/Urea aqueous solution. Carbohyd Polym 185:12–1810.1016/j.carbpol.2017.12.055 ↗
32. Wang SS, Chen JJ, Li LC et al (2022) Mass transfer behavior of methane in porous carbon materials. AIChE J 68:e1752110.1002/aic.17521 ↗
33. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–3810.1016/0263-7855(96)00018-5 ↗
34. Lu T, Chen F (2012) Multiwfn: A multifunctional wavefunction analyzer. J Comput Chem 33:580–59210.1002/jcc.22885 ↗
35. Grimme S, Bannwarth C, Shushkov P (2017) A robust and accurate tight-binding quantum chemical method for structures, vibrational frequencies, and noncovalent interactions of large molecular systems parametrized for all spd-block elements (Z=1-86). J Chem Theory Comput 13:1989–200910.1021/acs.jctc.7b00118 ↗
36. Carr AC, Piunova VA, Maarof H et al (2018) Influence of solvent on the drug-loading process of amphiphilic nanogel star polymers. J Phys Chem B 122:5356–536710.1021/acs.jpcb.7b10539 ↗
37. Meunier M, Goupil A, Lienard P (2017) Predicting drug loading in PLA-PEG nanoparticles. Int J Pharm 526:157–16610.1016/j.ijpharm.2017.04.043 ↗
38. Lefebvre C, Rubez G, Khartabil H (2017) Accurately extracting the signature of intermolecular interactions present in the NCI plot of the reduced density gradient versus electron density. PCCP 19:17928–1793610.1039/C7CP02110K ↗
39. Huang D, Zhuang YP, Shen H (2018) pH-Responsive nanoparticles based on ibuprofen prodrug as drug carriers for inhibition of primary tumor growth and metastasis. Mat Sci Eng C 82:60–6810.1016/j.msec.2017.08.063 ↗
40. Jones MC, Leroux JC (1999) Polymeric micelles-a new generation of colloidal drug carriers. Eur J Pharm Biopharm 48:101–11110.1016/S0939-6411(99)00039-9 ↗
41. Kirtane AR, Narayan P, Liu G (2017) Polymer-surfactant nanoparticles for improving oral bioavailability of doxorubicin. J Pharm Investig 47:65–7310.1007/s40005-016-0293-5 ↗